These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37212065)

  • 1. Multifactorial Modeling of Cognitive Trajectories Using an Advanced Regression Technique: Improving Our Understanding of Biomarkers and Modifiable Variables that Support Cognition.
    Fletcher E
    J Alzheimers Dis; 2023; 93(2):815-819. PubMed ID: 37212065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial Least Squares Regression Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognitive Change in Older Adults with Mild Cognitive Impairment.
    Stark J; Hiersche KJ; Yu JC; Hasselbach AN; Abdi H; Hayes SM;
    J Alzheimers Dis; 2023; 93(2):633-651. PubMed ID: 37066909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial Least Squares Analysis of Alzheimer's Disease Biomarkers, Modifiable Health Variables, and Cognition in Older Adults with Mild Cognitive Impairment.
    Stark J; Palombo DJ; Hayes JP; Hiersche KJ; Hasselbach AN; Hayes SM;
    J Int Neuropsychol Soc; 2022 Sep; 28(8):781-789. PubMed ID: 34664547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease.
    Marshall GA; Rentz DM; Frey MT; Locascio JJ; Johnson KA; Sperling RA;
    Alzheimers Dement; 2011 May; 7(3):300-8. PubMed ID: 21575871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Alzheimer's disease biomarkers as mediators of age-related cognitive decline.
    Hohman TJ; Tommet D; Marks S; Contreras J; Jones R; Mungas D;
    Neurobiol Aging; 2017 Oct; 58():120-128. PubMed ID: 28732249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
    Lim YY; Ellis KA; Harrington K; Ames D; Martins RN; Masters CL; Rowe C; Savage G; Szoeke C; Darby D; Maruff P; The Aibl Research Group
    J Clin Exp Neuropsychol; 2012; 34(4):345-58. PubMed ID: 22248010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease risk factors as mediators of subjective memory impairment and objective memory decline: protocol for a construct-level replication analysis.
    Hill NL; Mogle J
    BMC Geriatr; 2018 Oct; 18(1):260. PubMed ID: 30373526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding heterogeneity in older adults: Latent growth curve modeling of cognitive functioning.
    MacAulay RK; Calamia MR; Cohen AS; Daigle K; Foil H; Brouillette R; Bruce-Keller AJ; Keller JN
    J Clin Exp Neuropsychol; 2018 Apr; 40(3):292-302. PubMed ID: 28669314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introductory editorial to the special issue: Alzheimer's disease biomarkers and cognitive functioning along the Alzheimer's continuum.
    Butts AM; Haut MW
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023; 30(6):861-865. PubMed ID: 37632292
    [No Abstract]   [Full Text] [Related]  

  • 14. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype.
    Rettberg JR; Dang H; Hodis HN; Henderson VW; St John JA; Mack WJ; Brinton RD
    Neurobiol Aging; 2016 Apr; 40():155-163. PubMed ID: 26973115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer's disease.
    Roy S; Drake A; Snyder S; Cline B; Khan A; Fuchs T; Zivadinov R; Weinstock-Guttman B; Szigeti K; Benedict RHB
    Mult Scler Relat Disord; 2018 May; 22():52-56. PubMed ID: 29574353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
    J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition from mild cognitive impairment to normal cognition: Determining the predictors of reversion with multi-state Markov models.
    Sanz-Blasco R; Ruiz-Sánchez de León JM; Ávila-Villanueva M; Valentí-Soler M; Gómez-Ramírez J; Fernández-Blázquez MA
    Alzheimers Dement; 2022 Jun; 18(6):1177-1185. PubMed ID: 34482637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.